Diacon A.H. Dawson R. Hanekom M. Narunsky K. Venter A. Hittel N. Geiter L.J. Wells C.D. Paccaly A.J. Donald P.R.
(2011)
BACKGROUND: Delamanid (OPC-67683) is a novel mycolic acid biosynthesis inhibitor active against Mycobacterium tuberculosis at a low minimum inhibitory concentration. METHODS: Forty-eight patients with smear-positive ...